Literature DB >> 26814351

Altered states part 2: addressing nausea in canine research subjects.

Victoria Hampshire1.   

Abstract

Nausea and emesis can occur for multiple reasons. While research staff can readily empathize with this type of discomfort, proper assessment and treatment can be challenging. In order to provide optimal care for canine research subjects, it is critical that institutions develop a treatment plan and take preemptive measures to control nausea and emesis when they occur.

Entities:  

Mesh：

Year:  2016        PMID： 26814351     DOI： 10.1038/laban.931

Source DB:  PubMed          Journal:  Lab Anim (NY)        ISSN： 0093-7355            Impact factor:   12.625


  10 in total

Review 1.  Antiemetic prophylaxis: pharmacology and therapeutics.

Authors:  Carol L Norred
Journal:  AANA J       Date:  2003-04

2.  Application of a scaling model to establish and validate an interval level pain scale for assessment of acute pain in dogs.

Authors:  Carolyn M Morton; Jacky Reid; E Marion Scott; Lynne L Holton; Andrea M Nolan
Journal:  Am J Vet Res       Date:  2005-12       Impact factor: 1.156

3.  Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.

Authors:  H A Benchaoui; E M Siedek; V A De La Puente-Redondo; N Tilt; T G Rowan; R G Clemence
Journal:  Vet Rec       Date:  2007-09-29       Impact factor: 2.695

4.  Comparison of surgical variables and short-term postoperative complications in healthy dogs undergoing ovariohysterectomy or ovariectomy.

Authors:  Marijke E Peeters; Jolle Kirpensteijn
Journal:  J Am Vet Med Assoc       Date:  2011-01-15       Impact factor: 1.936

5.  The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.

Authors:  V A de la Puente-Redondo; E M Siedek; H A Benchaoui; N Tilt; T G Rowan; R G Clemence
Journal:  J Small Anim Pract       Date:  2007-02       Impact factor: 1.522

6.  Evaluation of intraperitoneal and incisional lidocaine or bupivacaine for analgesia following ovariohysterectomy in the dog.

Authors:  Rachael E Carpenter; Deborah V Wilson; A Thomas Evans
Journal:  Vet Anaesth Analg       Date:  2004-01       Impact factor: 1.648

7.  Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands.

Authors:  J C Murrell; E P Psatha; E M Scott; J Reid; L J Hellebrekers
Journal:  Vet Rec       Date:  2008-03-29       Impact factor: 2.695

8.  Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.

Authors:  G A Conder; H S Sedlacek; J F Boucher; R G Clemence
Journal:  J Vet Pharmacol Ther       Date:  2008-12       Impact factor: 1.786

9.  Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.

Authors:  D S Ramsey; K Kincaid; J A Watkins; J F Boucher; G A Conder; J S Eagleson; R G Clemence
Journal:  J Vet Pharmacol Ther       Date:  2008-12       Impact factor: 1.786

Review 10.  Emesis in dogs: a review.

Authors:  C Elwood; P Devauchelle; J Elliott; V Freiche; A J German; M Gualtieri; E Hall; E den Hertog; R Neiger; D Peeters; X Roura; K Savary-Bataille
Journal:  J Small Anim Pract       Date:  2010-01       Impact factor: 1.522
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.